Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6469119

COc1cc(OC)c2nc(Nc3nc(O)c4c5c(ccc4n3)OCO5)nc(C)c2c1.O=C(O)C(F)(F)F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.39
ALDH1A1 P00352 10/20 0.39
HPGD P15428 4/20 0.39
LMNA P02545 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
PKM P14618 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39
MEN1 O00255 4/20 0.35
KMT2A Q03164 4/20 0.35
POLB P06746 2/20 0.35
RAB9A P51151 3/20 0.34
NPC1 O15118 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP2 O95551 1/20 0.34
PDE5A O76074 1/20 0.34
MAPT P10636 6/20 0.33
PSMD14 O00487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6469146 0.92 KDM4E (0.40) KDM4EALDH1A1HPGDLMNANPSR1
Trifluoroacetic Acid SCHEMBL6471160 0.88 KDM4E (0.42) KDM4EALDH1A1HPGDLMNANPSR1
SCHEMBL6469121 0.87 KDM4E (0.39) KDM4EALDH1A1HPGDLMNANPSR1
Trifluoroacetic Acid SCHEMBL6467073 0.83 KMT2A (0.39) KDM4EALDH1A1LMNANPSR1MEN1
Trifluoroacetic Acid SCHEMBL6468650 0.83 KMT2A (0.38) KDM4EALDH1A1LMNANPSR1MEN1
Trifluoroacetic Acid SCHEMBL6470460 0.81 KMT2A (0.35) KDM4EALDH1A1LMNANPSR1MEN1
Trifluoroacetic Acid SCHEMBL6470070 0.79 KMT2A (0.36) KDM4EALDH1A1NPSR1MEN1KMT2A
Trifluoroacetic Acid SCHEMBL6468695 0.79 AURKA (0.38) KDM4EALDH1A1HPGDLMNANPSR1
Trifluoroacetic Acid SCHEMBL6467382 0.78 ALDH1A1 (0.38) KDM4EALDH1A1HPGDLMNANPSR1
SCHEMBL6468658 0.77 KMT2A (0.36) KDM4EALDH1A1NPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US claimed
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections REPLIDYNE, INC. 2005-06-09 US disclosed
WO-2005030131-A2 BIS-QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS REPLIDYNE, INC (US) 2005-04-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124562-A1 Bis-quinazoline compounds for the treatment of bacterial infections POLI, POLK, POLB KDM4E 3225/4885ALDH1A1 3154/4885HPGD 765/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.